Numbers and Facts
- Founding of RHEACELL in 2012
- Subsidiary of TICEBA GmbH
- Start of business activities in July 2012
- Offices and laboratory at technology park Heidelberg
- 9 employees
Mission and Vision
RHEACELL is dedicated to the development of human pharmaceuticals based on ABCB5+ mesenchymal stem cells. For selected indications RHEACELL strives to improve the quality of life as well as to alleviate and heal ailments of patients.
RHEACELL is obligated to meet the requirements of the European law throughout the whole development process of stem cell-based pharmaceuticals. Also, latest international findings of science and research as well as in-house know-how of RHEACELL's qualified staff play a key role in realizing the mission. Throughout the entire development process, the requirements of Good Manufacturing Practice, Good Laboratory Practice und Good Clinical Practice are met.